APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alectinib

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Alectinib Market Analysis and Forecast 2026-2032

23 December 2025196 pages

Choose your research edition.

Industry ResearchAlectinib Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Alectinib Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Alectinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alectinib Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Alectinib Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Alectinib market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Alectinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Alectinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Alectinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Alectinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Alectinib include Roche and Everest Pharmaceuticals etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Alectinib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Alectinib, also provides the sales of main regions and countries. Of the upcoming market potential for Alectinib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Alectinib sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Alectinib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Alectinib sales, projected growth trends, production technology, application and end-user industry.

Alectinib Segment by Company

Roche

Everest Pharmaceuticals

Alectinib Segment by Type

150mg*140 Capsules

150mg*26 Capsules

150mg*28 Capsules

20mg*1 Capsule

40mg*1 Capsule

Alectinib Segment by Application

Advanced NSCLC

Recurrent NSCLC

Unresectable NSCLC

Others

Alectinib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alectinib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alectinib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alectinib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Alectinib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Alectinib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alectinib sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Alectinib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 150mg*140 Capsules Major Manufacturers Table 3. 150mg*26 Capsules Major Manufacturers Table 4. 150mg*28 Capsules Major Manufacturers Table 5. 20mg*1 Capsule Major Manufacturers Table 6. 40mg*1 Capsule Major Manufacturers Table 7. Global Alectinib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Advanced NSCLC Major Manufacturers Table 9. Recurrent NSCLC Major Manufacturers Table 10. Unresectable NSCLC Major Manufacturers Table 11. Others Major Manufacturers Table 12. Alectinib Industry Trends Table 13. Alectinib Industry Drivers Table 14. Alectinib Industry Opportunities and Challenges Table 15. Alectinib Industry Restraints Table 16. Global Alectinib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Alectinib Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Alectinib Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Alectinib Revenue Market Share by Region (2021-2026) Table 20. Global Alectinib Revenue Market Share by Region (2027-2032) Table 21. Global Alectinib Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 22. Global Alectinib Sales by Region (2021-2026) & (k units) Table 23. Global Alectinib Sales by Region (2027-2032) & (k units) Table 24. Global Alectinib Sales Market Share by Region (2021-2026) Table 25. Global Alectinib Sales Market Share by Region (2027-2032) Table 26. Global Alectinib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Alectinib Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Alectinib Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Alectinib Sales Market Share by Manufacturers (2021-2026) Table 30. Global Alectinib Sales Price (US$/unit) of Manufacturers (2021-2026) Table 31. Global Alectinib Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Alectinib Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Alectinib Manufacturers, Product Type & Application Table 34. Global Alectinib Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Alectinib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Alectinib Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Alectinib Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Alectinib Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Alectinib Revenue Market Share by Type (2021-2026) Table 41. Global Alectinib Revenue Market Share by Type (2027-2032) Table 42. Global Alectinib Sales by Type 2021 VS 2025 VS 2032 (k units) Table 43. Global Alectinib Sales by Type (2021-2026) & (k units) Table 44. Global Alectinib Sales by Type (2027-2032) & (k units) Table 45. Global Alectinib Sales Market Share by Type (2021-2026) Table 46. Global Alectinib Sales Market Share by Type (2027-2032) Table 47. Global Alectinib Price by Type (2021-2026) & (US$/unit) Table 48. Global Alectinib Price by Type (2027-2032) & (US$/unit) Table 49. Global Alectinib Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Alectinib Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Alectinib Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Alectinib Revenue Market Share by Application (2021-2026) Table 53. Global Alectinib Revenue Market Share by Application (2027-2032) Table 54. Global Alectinib Sales by Application 2021 VS 2025 VS 2032 (k units) Table 55. Global Alectinib Sales by Application (2021-2026) & (k units) Table 56. Global Alectinib Sales by Application (2027-2032) & (k units) Table 57. Global Alectinib Sales Market Share by Application (2021-2026) Table 58. Global Alectinib Sales Market Share by Application (2027-2032) Table 59. Global Alectinib Price by Application (2021-2026) & (US$/unit) Table 60. Global Alectinib Price by Application (2027-2032) & (US$/unit) Table 61. Roche Company Information Table 62. Roche Business Overview Table 63. Roche Alectinib Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Roche Alectinib Product Portfolio Table 65. Roche Recent Development Table 66. Everest Pharmaceuticals Company Information Table 67. Everest Pharmaceuticals Business Overview Table 68. Everest Pharmaceuticals Alectinib Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Everest Pharmaceuticals Alectinib Product Portfolio Table 70. Everest Pharmaceuticals Recent Development Table 71. North America Alectinib Revenue by Type (2021-2026) & (US$ Million) Table 72. North America Alectinib Revenue by Type (2027-2032) & (US$ Million) Table 73. North America Alectinib Sales by Type (2021-2026) & (k units) Table 74. North America Alectinib Sales by Type (2027-2032) & (k units) Table 75. North America Alectinib Sales Price by Type (2021-2026) & (US$/unit) Table 76. North America Alectinib Sales Price by Type (2027-2032) & (US$/unit) Table 77. North America Alectinib Revenue by Application (2021-2026) & (US$ Million) Table 78. North America Alectinib Revenue by Application (2027-2032) & (US$ Million) Table 79. North America Alectinib Sales by Application (2021-2026) & (k units) Table 80. North America Alectinib Sales by Application (2027-2032) & (k units) Table 81. North America Alectinib Sales Price by Application (2021-2026) & (US$/unit) Table 82. North America Alectinib Sales Price by Application (2027-2032) & (US$/unit) Table 83. North America Alectinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. North America Alectinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 85. North America Alectinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 86. North America Alectinib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 87. North America Alectinib Sales by Country (2021-2026) & (k units) Table 88. North America Alectinib Sales by Country (2027-2032) & (k units) Table 89. North America Alectinib Sales Price by Country (2021-2026) & (US$/unit) Table 90. North America Alectinib Sales Price by Country (2027-2032) & (US$/unit) Table 91. United States Alectinib Revenue (2021-2032) & (US$ Million) Table 92. Canada Alectinib Revenue (2021-2032) & (US$ Million) Table 93. Mexico Alectinib Revenue (2021-2032) & (US$ Million) Table 94. Europe Alectinib Revenue by Type (2021-2026) & (US$ Million) Table 95. Europe Alectinib Revenue by Type (2027-2032) & (US$ Million) Table 96. Europe Alectinib Sales by Type (2021-2026) & (k units) Table 97. Europe Alectinib Sales by Type (2027-2032) & (k units) Table 98. Europe Alectinib Sales Price by Type (2021-2026) & (US$/unit) Table 99. Europe Alectinib Sales Price by Type (2027-2032) & (US$/unit) Table 100. Europe Alectinib Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe Alectinib Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe Alectinib Sales by Application (2021-2026) & (k units) Table 103. Europe Alectinib Sales by Application (2027-2032) & (k units) Table 104. Europe Alectinib Sales Price by Application (2021-2026) & (US$/unit) Table 105. Europe Alectinib Sales Price by Application (2027-2032) & (US$/unit) Table 106. Europe Alectinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Alectinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 108. Europe Alectinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 109. Europe Alectinib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 110. Europe Alectinib Sales by Country (2021-2026) & (k units) Table 111. Europe Alectinib Sales by Country (2027-2032) & (k units) Table 112. Europe Alectinib Sales Price by Country (2021-2026) & (US$/unit) Table 113. Europe Alectinib Sales Price by Country (2027-2032) & (US$/unit) Table 114. Germany Alectinib Revenue (2021-2032) & (US$ Million) Table 115. France Alectinib Revenue (2021-2032) & (US$ Million) Table 116. U.K. Alectinib Revenue (2021-2032) & (US$ Million) Table 117. Italy Alectinib Revenue (2021-2032) & (US$ Million) Table 118. Russia Alectinib Revenue (2021-2032) & (US$ Million) Table 119. Spain Alectinib Revenue (2021-2032) & (US$ Million) Table 120. Netherlands Alectinib Revenue (2021-2032) & (US$ Million) Table 121. Switzerland Alectinib Revenue (2021-2032) & (US$ Million) Table 122. Sweden Alectinib Revenue (2021-2032) & (US$ Million) Table 123. Poland Alectinib Revenue (2021-2032) & (US$ Million) Table 124. China Alectinib Revenue by Type (2021-2026) & (US$ Million) Table 125. China Alectinib Revenue by Type (2027-2032) & (US$ Million) Table 126. China Alectinib Sales by Type (2021-2026) & (k units) Table 127. China Alectinib Sales by Type (2027-2032) & (k units) Table 128. China Alectinib Sales Price by Type (2021-2026) & (US$/unit) Table 129. China Alectinib Sales Price by Type (2027-2032) & (US$/unit) Table 130. China Alectinib Revenue by Application (2021-2026) & (US$ Million) Table 131. China Alectinib Revenue by Application (2027-2032) & (US$ Million) Table 132. China Alectinib Sales by Application (2021-2026) & (k units) Table 133. China Alectinib Sales by Application (2027-2032) & (k units) Table 134. China Alectinib Sales Price by Application (2021-2026) & (US$/unit) Table 135. China Alectinib Sales Price by Application (2027-2032) & (US$/unit) Table 136. Asia Alectinib Revenue by Type (2021-2026) & (US$ Million) Table 137. Asia Alectinib Revenue by Type (2027-2032) & (US$ Million) Table 138. Asia Alectinib Sales by Type (2021-2026) & (k units) Table 139. Asia Alectinib Sales by Type (2027-2032) & (k units) Table 140. Asia Alectinib Sales Price by Type (2021-2026) & (US$/unit) Table 141. Asia Alectinib Sales Price by Type (2027-2032) & (US$/unit) Table 142. Asia Alectinib Revenue by Application (2021-2026) & (US$ Million) Table 143. Asia Alectinib Revenue by Application (2027-2032) & (US$ Million) Table 144. Asia Alectinib Sales by Application (2021-2026) & (k units) Table 145. Asia Alectinib Sales by Application (2027-2032) & (k units) Table 146. Asia Alectinib Sales Price by Application (2021-2026) & (US$/unit) Table 147. Asia Alectinib Sales Price by Application (2027-2032) & (US$/unit) Table 148. Asia Alectinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Asia Alectinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. Asia Alectinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. Asia Alectinib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 152. Asia Alectinib Sales by Country (2021-2026) & (k units) Table 153. Asia Alectinib Sales by Country (2027-2032) & (k units) Table 154. Asia Alectinib Sales Price by Country (2021-2026) & (US$/unit) Table 155. Asia Alectinib Sales Price by Country (2027-2032) & (US$/unit) Table 156. Japan Alectinib Revenue (2021-2032) & (US$ Million) Table 157. South Korea Alectinib Revenue (2021-2032) & (US$ Million) Table 158. India Alectinib Revenue (2021-2032) & (US$ Million) Table 159. Australia Alectinib Revenue (2021-2032) & (US$ Million) Table 160. Taiwan Alectinib Revenue (2021-2032) & (US$ Million) Table 161. Southeast Asia Alectinib Revenue (2021-2032) & (US$ Million) Table 162. SAMEA Alectinib Revenue by Type (2021-2026) & (US$ Million) Table 163. SAMEA Alectinib Revenue by Type (2027-2032) & (US$ Million) Table 164. SAMEA Alectinib Sales by Type (2021-2026) & (k units) Table 165. SAMEA Alectinib Sales by Type (2027-2032) & (k units) Table 166. SAMEA Alectinib Sales Price by Type (2021-2026) & (US$/unit) Table 167. SAMEA Alectinib Sales Price by Type (2027-2032) & (US$/unit) Table 168. SAMEA Alectinib Revenue by Application (2021-2026) & (US$ Million) Table 169. SAMEA Alectinib Revenue by Application (2027-2032) & (US$ Million) Table 170. SAMEA Alectinib Sales by Application (2021-2026) & (k units) Table 171. SAMEA Alectinib Sales by Application (2027-2032) & (k units) Table 172. SAMEA Alectinib Sales Price by Application (2021-2026) & (US$/unit) Table 173. SAMEA Alectinib Sales Price by Application (2027-2032) & (US$/unit) Table 174. SAMEA Alectinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. SAMEA Alectinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. SAMEA Alectinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. SAMEA Alectinib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 178. SAMEA Alectinib Sales by Country (2021-2026) & (k units) Table 179. SAMEA Alectinib Sales by Country (2027-2032) & (k units) Table 180. SAMEA Alectinib Sales Price by Country (2021-2026) & (US$/unit) Table 181. SAMEA Alectinib Sales Price by Country (2027-2032) & (US$/unit) Table 182. Brazil Alectinib Revenue (2021-2032) & (US$ Million) Table 183. Argentina Alectinib Revenue (2021-2032) & (US$ Million) Table 184. Chile Alectinib Revenue (2021-2032) & (US$ Million) Table 185. Colombia Alectinib Revenue (2021-2032) & (US$ Million) Table 186. Peru Alectinib Revenue (2021-2032) & (US$ Million) Table 187. Saudi Arabia Alectinib Revenue (2021-2032) & (US$ Million) Table 188. Israel Alectinib Revenue (2021-2032) & (US$ Million) Table 189. UAE Alectinib Revenue (2021-2032) & (US$ Million) Table 190. Turkey Alectinib Revenue (2021-2032) & (US$ Million) Table 191. Iran Alectinib Revenue (2021-2032) & (US$ Million) Table 192. Egypt Alectinib Revenue (2021-2032) & (US$ Million) Table 193. Key Raw Materials Table 194. Raw Materials Key Suppliers Table 195. Alectinib Distributors List Table 196. Alectinib Customers List Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. Alectinib Image Figure 2. Global Alectinib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alectinib Market Size Share 2021 VS 2025 VS 2032 Figure 4. 150mg*140 Capsules Image Figure 5. 150mg*26 Capsules Image Figure 6. 150mg*28 Capsules Image Figure 7. 20mg*1 Capsule Image Figure 8. 40mg*1 Capsule Image Figure 9. Global Alectinib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Alectinib Market Size Share 2021 VS 2025 VS 2032 Figure 11. Advanced NSCLC Image Figure 12. Recurrent NSCLC Image Figure 13. Unresectable NSCLC Image Figure 14. Others Image Figure 15. Global Alectinib Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Alectinib Revenue (2021-2032) & (US$ Million) Figure 17. Global Alectinib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Alectinib Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Alectinib Revenue Market Share by Region (2021-2032) Figure 20. Global Alectinib Sales (2021-2032) & (k units) Figure 21. Global Alectinib Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 22. Global Alectinib Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Alectinib Sales YoY (2021-2032) & (k units) Figure 24. Europe Alectinib Sales YoY (2021-2032) & (k units) Figure 25. China Alectinib Sales YoY (2021-2032) & (k units) Figure 26. Asia (Excluding China) Alectinib Sales YoY (2021-2032) & (k units) Figure 27. South America, Middle East and Africa Alectinib Sales YoY (2021-2032) & (k units) Figure 28. Global Alectinib Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Alectinib Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Alectinib Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Alectinib Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Alectinib Revenue Market Share by Type (2021-2032) Figure 34. Global Alectinib Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 35. Global Alectinib Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Alectinib Sales Market Share by Type (2021-2032) Figure 37. Global Alectinib Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Alectinib Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Alectinib Revenue Market Share by Application (2021-2032) Figure 40. Global Alectinib Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 41. Global Alectinib Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Alectinib Sales Market Share by Application (2021-2032) Figure 43. North America Alectinib Revenue Share by Type (2021-2032) Figure 44. North America Alectinib Sales Share by Type (2021-2032) Figure 45. North America Alectinib Revenue Share by Application (2021-2032) Figure 46. North America Alectinib Sales Share by Application (2021-2032) Figure 47. North America Alectinib Revenue Share by Country (2021-2032) Figure 48. North America Alectinib Sales Share by Country (2021-2032) Figure 49. Europe Alectinib Revenue Share by Type (2021-2032) Figure 50. Europe Alectinib Sales Share by Type (2021-2032) Figure 51. Europe Alectinib Revenue Share by Application (2021-2032) Figure 52. Europe Alectinib Sales Share by Application (2021-2032) Figure 53. Europe Alectinib Revenue Share by Country (2021-2032) Figure 54. Europe Alectinib Sales Share by Country (2021-2032) Figure 55. China Alectinib Revenue Share by Type (2021-2032) Figure 56. China Alectinib Sales Share by Type (2021-2032) Figure 57. China Alectinib Revenue Share by Application (2021-2032) Figure 58. China Alectinib Sales Share by Application (2021-2032) Figure 59. Asia Alectinib Revenue Share by Type (2021-2032) Figure 60. Asia Alectinib Sales Share by Type (2021-2032) Figure 61. Asia Alectinib Revenue Share by Application (2021-2032) Figure 62. Asia Alectinib Sales Share by Application (2021-2032) Figure 63. Asia Alectinib Revenue Share by Country (2021-2032) Figure 64. Asia Alectinib Sales Share by Country (2021-2032) Figure 65. SAMEA Alectinib Revenue Share by Type (2021-2032) Figure 66. SAMEA Alectinib Sales Share by Type (2021-2032) Figure 67. SAMEA Alectinib Revenue Share by Application (2021-2032) Figure 68. SAMEA Alectinib Sales Share by Application (2021-2032) Figure 69. SAMEA Alectinib Revenue Share by Country (2021-2032) Figure 70. SAMEA Alectinib Sales Share by Country (2021-2032) Figure 71. Alectinib Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Alectinib Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • 150mg*140 Capsules
  • 150mg*26 Capsules
  • 150mg*28 Capsules
  • 20mg*1 Capsule
  • 40mg*1 Capsule
Applications
  • Advanced NSCLC
  • Recurrent NSCLC
  • Unresectable NSCLC
  • Others
Companies covered
  • Roche
  • Everest Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Alectinib Market by Type
  3. 1.2.1 Global Alectinib Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 150mg*140 Capsules
  5. 1.2.3 150mg*26 Capsules
  6. 1.2.4 150mg*28 Capsules
  7. 1.2.5 20mg*1 Capsule
  8. 1.2.6 40mg*1 Capsule
  9. 1.3 Alectinib Market by Application
  10. 1.3.1 Global Alectinib Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Advanced NSCLC
  12. 1.3.3 Recurrent NSCLC
  13. 1.3.4 Unresectable NSCLC
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Alectinib Market Dynamics
  1. 2.1 Alectinib Industry Trends
  2. 2.2 Alectinib Industry Drivers
  3. 2.3 Alectinib Industry Opportunities and Challenges
  4. 2.4 Alectinib Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Alectinib Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Alectinib Revenue by Region
  3. 3.2.1 Global Alectinib Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Alectinib Revenue by Region (2021-2026)
  5. 3.2.3 Global Alectinib Revenue by Region (2027-2032)
  6. 3.2.4 Global Alectinib Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Alectinib Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Alectinib Sales by Region
  9. 3.4.1 Global Alectinib Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Alectinib Sales by Region (2021-2026)
  11. 3.4.3 Global Alectinib Sales by Region (2027-2032)
  12. 3.4.4 Global Alectinib Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Alectinib Revenue by Manufacturers
  2. 4.1.1 Global Alectinib Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Alectinib Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Alectinib Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Alectinib Sales by Manufacturers
  6. 4.2.1 Global Alectinib Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Alectinib Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Alectinib Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Alectinib Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Alectinib Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Alectinib Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Alectinib Manufacturers, Product Type & Application
  13. 4.7 Global Alectinib Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Alectinib Market CR5 and HHI
  16. 4.8.2 2025 Alectinib Tier 1, Tier 2, and Tier 3
5 Alectinib Market by Type
  1. 5.1 Global Alectinib Revenue by Type
  2. 5.1.1 Global Alectinib Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Alectinib Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Alectinib Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Alectinib Sales by Type
  6. 5.2.1 Global Alectinib Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Alectinib Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Alectinib Sales Market Share by Type (2021-2032)
  9. 5.3 Global Alectinib Price by Type
6 Alectinib Market by Application
  1. 6.1 Global Alectinib Revenue by Application
  2. 6.1.1 Global Alectinib Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Alectinib Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Alectinib Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Alectinib Sales by Application
  6. 6.2.1 Global Alectinib Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Alectinib Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Alectinib Sales Market Share by Application (2021-2032)
  9. 6.3 Global Alectinib Price by Application
7 Company Profiles
  1. 7.1 Roche
  2. 7.1.1 Roche Company Information
  3. 7.1.2 Roche Business Overview
  4. 7.1.3 Roche Alectinib Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Roche Alectinib Product Portfolio
  6. 7.1.5 Roche Recent Developments
  7. 7.2 Everest Pharmaceuticals
  8. 7.2.1 Everest Pharmaceuticals Company Information
  9. 7.2.2 Everest Pharmaceuticals Business Overview
  10. 7.2.3 Everest Pharmaceuticals Alectinib Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Everest Pharmaceuticals Alectinib Product Portfolio
  12. 7.2.5 Everest Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Alectinib Market Size by Type
  2. 8.1.1 North America Alectinib Revenue by Type (2021-2032)
  3. 8.1.2 North America Alectinib Sales by Type (2021-2032)
  4. 8.1.3 North America Alectinib Price by Type (2021-2032)
  5. 8.2 North America Alectinib Market Size by Application
  6. 8.2.1 North America Alectinib Revenue by Application (2021-2032)
  7. 8.2.2 North America Alectinib Sales by Application (2021-2032)
  8. 8.2.3 North America Alectinib Price by Application (2021-2032)
  9. 8.3 North America Alectinib Market Size by Country
  10. 8.3.1 North America Alectinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Alectinib Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Alectinib Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Alectinib Market Size by Type
  2. 9.1.1 Europe Alectinib Revenue by Type (2021-2032)
  3. 9.1.2 Europe Alectinib Sales by Type (2021-2032)
  4. 9.1.3 Europe Alectinib Price by Type (2021-2032)
  5. 9.2 Europe Alectinib Market Size by Application
  6. 9.2.1 Europe Alectinib Revenue by Application (2021-2032)
  7. 9.2.2 Europe Alectinib Sales by Application (2021-2032)
  8. 9.2.3 Europe Alectinib Price by Application (2021-2032)
  9. 9.3 Europe Alectinib Market Size by Country
  10. 9.3.1 Europe Alectinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Alectinib Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Alectinib Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Alectinib Market Size by Type
  2. 10.1.1 China Alectinib Revenue by Type (2021-2032)
  3. 10.1.2 China Alectinib Sales by Type (2021-2032)
  4. 10.1.3 China Alectinib Price by Type (2021-2032)
  5. 10.2 China Alectinib Market Size by Application
  6. 10.2.1 China Alectinib Revenue by Application (2021-2032)
  7. 10.2.2 China Alectinib Sales by Application (2021-2032)
  8. 10.2.3 China Alectinib Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Alectinib Market Size by Type
  2. 11.1.1 Asia Alectinib Revenue by Type (2021-2032)
  3. 11.1.2 Asia Alectinib Sales by Type (2021-2032)
  4. 11.1.3 Asia Alectinib Price by Type (2021-2032)
  5. 11.2 Asia Alectinib Market Size by Application
  6. 11.2.1 Asia Alectinib Revenue by Application (2021-2032)
  7. 11.2.2 Asia Alectinib Sales by Application (2021-2032)
  8. 11.2.3 Asia Alectinib Price by Application (2021-2032)
  9. 11.3 Asia Alectinib Market Size by Country
  10. 11.3.1 Asia Alectinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Alectinib Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Alectinib Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Alectinib Market Size by Type
  2. 12.1.1 SAMEA Alectinib Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Alectinib Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Alectinib Price by Type (2021-2032)
  5. 12.2 SAMEA Alectinib Market Size by Application
  6. 12.2.1 SAMEA Alectinib Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Alectinib Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Alectinib Price by Application (2021-2032)
  9. 12.3 SAMEA Alectinib Market Size by Country
  10. 12.3.1 SAMEA Alectinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Alectinib Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Alectinib Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Alectinib Value Chain Analysis
  2. 13.1.1 Alectinib Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Alectinib Production Mode & Process
  6. 13.2 Alectinib Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Alectinib Distributors
  9. 13.2.3 Alectinib Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst